EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Efferocytosis induces proangiogenic function and chromatin remodeling in tumor-associated macrophages

Roi Balaban, Ori Moskowitz, Maiia Levinson, Noam Ofer, Alice Raizman, Gaya Levi Kitron, Eden Aviv, Sandra Camargo, Lihi Goldman, Aviv Leemann, Eden Noachas, Chen Sharon-Yagol, Amir Giladi, Merav Cohen

Science Immunology · 2026-06-05 · 11 (120)

DOI: 10.1126/sciimmunol.aed1544 ↗
AbstractBibliografische Angaben

Abstract

Macrophages remove apoptotic cells by efferocytosis during immune surveillance and in the tumor microenvironment (TME). However, the gradual molecular and epigenetic consequences of efferocytosis in single macrophages remain unclear. Here, we introduce Effero-seq, an approach that captures single-cell transcriptomic changes coupled with lysosomal acidification tracked by a pH-sensitive dye (pHrodo), thus enabling the dissection of molecular dynamics over time after engulfment. Using labeled apoptotic cells as cargo, we defined the effero-score, a gene program gradually up-regulated in correlation with pHrodo intensity. In a murine melanoma model, efferocytosis induced a proangiogenic function in macrophages with spatial proximity to vascular niches. Moreover, efferocytosis remodeled chromatin accessibility, leading to an attenuated macrophage response to interferon-γ. In human uveal melanoma, expression of the effero-score was correlated with poor survival. Therefore, Effero-seq sheds light on the molecular reprogramming induced by efferocytosis in the TME, opening previously unknown avenues for understanding macrophage function and developing targeted treatments.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →